Work

Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived

Year: 2017

Type: article

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2017.1323273

Authors: Sara Farshchi Zarabi, Steven Chan, Vikas Gupta, Dina Khalaf, Andrzej Lutynski, Mark D. Minden, Amr Rostom, Anna Rydlewski, Andre C. Schuh, Hassan Sibai, Karen W. L. Yee, Aaron D. Schimmer

Institution: Princess Margaret Cancer Centre

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Novartis, Incyte

OpenAlex ID: W2624583261

FWCI: 0.21

Cites: 10

Cited by: 2

Related to: 10